Industry News
Life Sciences
Top stories summarized by our editors
8/3/2020

The Trump administration's COVID-19 vaccine and drug initiative, Operation Warp Speed, has committed to purchase 100 million doses of Sanofi and GlaxoSmithKline's COVID-19 vaccine candidate in a deal worth up to $2.1 billion, the largest award given so far to a vaccine developer. The government has the option to buy an additional 500 million doses.

Full Story:
Politico
8/3/2020

A robot can perform autonomous nasal swab tests to reduce staff contact with infectious diseases. Taiwan-based Brain Navi has developed the robot in response to the COVID-19 pandemic.

Full Story:
MobiHealthNews
8/3/2020

Two of Siemens' blood tests, the Attelica COV2G and the ADVIA Centaur COV2G, are the first semi-quantitative assays to be approved by the FDA for use in the US for COVID-19 antibodies. The tests are able to measure the quantity of antibodies a patient has against the SARS-CoV-2 virus.

More Summaries:
Siemens
8/3/2020

The FDA has given emergency use authorization to Clinical Reference Laboratory for its saliva-based COVID-19 test.

8/3/2020

Seven companies were chosen by the NIH to receive funding for new technologies to boost their testing capacities and help them ramp up production of millions of coronavirus rapid tests to be made available by September 2020. A total of $248.7 million will be invested and shared by Mesa Biotech, Quidel and Talis Biomedical, Fluidigm, Ginkgo Bioworks, Helix OpCo and Mammoth Biosciences.

8/3/2020

Siemens Healthineers will acquire medical device and software maker Varian Medical Systems in a deal worth $16.4 billion.

8/3/2020

The Department of Defense and the HHS have given $24 million to Becton Dickinson to help boost production of its BD Veritor Plus SARS-CoV-2 assay.

8/3/2020

Sorrento Therapeutics has received the rights to Columbia University's COVI-TRACE, a fast saliva-based SARS-CoV-2 test that can deliver results within 30 minutes.

Full Story:
FDAnews
More Summaries:
Sorrento Therapeutics
8/3/2020

Researchers from the University Hospitals Leicester NHS Trust and Nottingham Trent University in the UK have created a blood test for prostate cancer that can determine the stage and progression of the disease with 99% accuracy.

Full Story:
Good News Network
8/3/2020

Sanofi ended its collaboration with Japan's Daaichi to develop a pediatric pentavalent vaccine. The companies were hoping to improve efforts in Japan to develop the vaccines as Japan is behind the rest of the world in their production.

Full Story:
FierceBiotech

Pages